Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1953 2
1954 1
1955 1
1958 2
1959 3
1962 1
1963 4
1964 6
1965 5
1966 3
1967 2
1968 5
1969 7
1970 7
1971 6
1972 2
1974 3
1975 1
1976 3
1977 6
1978 7
1979 2
1980 7
1981 6
1982 14
1983 10
1984 9
1985 12
1986 18
1987 11
1988 22
1989 32
1990 24
1991 15
1992 22
1993 24
1994 31
1995 34
1996 39
1997 49
1998 50
1999 56
2000 39
2001 51
2002 48
2003 43
2004 46
2005 67
2006 66
2007 64
2008 70
2009 63
2010 95
2011 106
2012 108
2013 76
2014 83
2015 73
2016 95
2017 102
2018 123
2019 120
2020 154
2021 193
2022 176
2023 201
2024 208
2025 83

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,776 results

Results by year

Filters applied: . Clear all
Page 1
DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1.
Ogitani Y, Aida T, Hagihara K, Yamaguchi J, Ishii C, Harada N, Soma M, Okamoto H, Oitate M, Arakawa S, Hirai T, Atsumi R, Nakada T, Hayakawa I, Abe Y, Agatsuma T. Ogitani Y, et al. Among authors: hirai t. Clin Cancer Res. 2016 Oct 15;22(20):5097-5108. doi: 10.1158/1078-0432.CCR-15-2822. Epub 2016 Mar 29. Clin Cancer Res. 2016. PMID: 27026201
Current advances in pulmonary functional imaging.
Nakamura H, Hirai T, Kurosawa H, Hamada K, Matsunaga K, Shimizu K, Konno S, Muro S, Fukunaga K, Nakano Y, Kuwahira I, Hanaoka M. Nakamura H, et al. Among authors: hirai t. Respir Investig. 2024 Jan;62(1):49-65. doi: 10.1016/j.resinv.2023.09.004. Epub 2023 Nov 8. Respir Investig. 2024. PMID: 37948969 Free article. Review.
Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.
Tazawa R, Ueda T, Abe M, Tatsumi K, Eda R, Kondoh S, Morimoto K, Tanaka T, Yamaguchi E, Takahashi A, Oda M, Ishii H, Izumi S, Sugiyama H, Nakagawa A, Tomii K, Suzuki M, Konno S, Ohkouchi S, Tode N, Handa T, Hirai T, Inoue Y, Arai T, Asakawa K, Sakagami T, Hashimoto A, Tanaka T, Takada T, Mikami A, Kitamura N, Nakata K. Tazawa R, et al. Among authors: hirai t. N Engl J Med. 2019 Sep 5;381(10):923-932. doi: 10.1056/NEJMoa1816216. N Engl J Med. 2019. PMID: 31483963 Clinical Trial.
An atlas of transcribed enhancers across helper T cell diversity for decoding human diseases.
Oguchi A, Suzuki A, Komatsu S, Yoshitomi H, Bhagat S, Son R, Bonnal RJP, Kojima S, Koido M, Takeuchi K, Myouzen K, Inoue G, Hirai T, Sano H, Takegami Y, Kanemaru A, Yamaguchi I, Ishikawa Y, Tanaka N, Hirabayashi S, Konishi R, Sekito S, Inoue T, Kere J, Takeda S, Takaori-Kondo A, Endo I, Kawaoka S, Kawaji H, Ishigaki K, Ueno H, Hayashizaki Y, Pagani M, Carninci P, Yanagita M; ITEC Consortium‡; Parrish N, Terao C, Yamamoto K, Murakawa Y; ITEC Consortium Members. Oguchi A, et al. Among authors: hirai t. Science. 2024 Jul 5;385(6704):eadd8394. doi: 10.1126/science.add8394. Epub 2024 Jul 5. Science. 2024. PMID: 38963856
"Crossing the invisible".
Hirai T. Hirai T. Catheter Cardiovasc Interv. 2023 Oct;102(4):774-775. doi: 10.1002/ccd.30780. Epub 2023 Jul 20. Catheter Cardiovasc Interv. 2023. PMID: 37471717 No abstract available.
Lung imaging in COPD and asthma.
Tanabe N, Nakagawa H, Sakao S, Ohno Y, Shimizu K, Nakamura H, Hanaoka M, Nakano Y, Hirai T. Tanabe N, et al. Among authors: hirai t. Respir Investig. 2024 Nov;62(6):995-1005. doi: 10.1016/j.resinv.2024.08.014. Epub 2024 Aug 29. Respir Investig. 2024. PMID: 39213987 Free article. Review.
Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8+ T cell cytotoxicity and proliferation.
Naito Y, Koyama S, Masuhiro K, Hirai T, Uenami T, Inoue T, Osa A, Machiyama H, Watanabe G, Sax N, Villa J, Kinugasa-Katayama Y, Nojima S, Yaga M, Hosono Y, Okuzaki D, Satoh S, Tsuda T, Nakanishi Y, Suga Y, Morita T, Fukushima K, Nishide M, Shiroyama T, Miyake K, Iwahori K, Hirata H, Nagatomo I, Yano Y, Tamiya M, Kumagai T, Takemoto N, Inohara H, Yamasaki S, Yamashita K, Aoshi T, Akbay EA, Hosen N, Shintani Y, Takamatsu H, Mori M, Takeda Y, Kumanogoh A. Naito Y, et al. Among authors: hirai t. Sci Adv. 2023 May 19;9(20):eade0718. doi: 10.1126/sciadv.ade0718. Epub 2023 May 19. Sci Adv. 2023. PMID: 37205755 Free PMC article.
2,776 results